Supplymentary Table 1 and Figure Legends from LASP1 Is a HIF1α Target Gene Critical for Metastasis of Pancreatic Cancer

Tiansuo Zhao,He Ren,Jing Li,Jing Chen,Huan Zhang,Wen Xin,Yan Sun,Lei Sun,Yongwei Yang,Junwei Sun,Xiuchao Wang,Song Gao,Chongbiao Huang,Huafeng Zhang,Shengyu Yang,Jihui Hao

DOI: https://doi.org/10.1158/0008-5472.22404594

2023-01-01

Abstract:Supplementary Table 1. Antibodies and primers.

What problem does this paper attempt to address?

Supplementary Tables from LIMS1 Promotes Pancreatic Cancer Cell Survival under Oxygen–Glucose Deprivation Conditions by Enhancing HIF1A Protein Translation

Chongbiao Huang,Yang Li,Zengxun Li,Yang Xu,Na Li,Yi Ge,Jie Dong,Antao Chang,Tiansuo Zhao,Xiuchao Wang,Hongwei Wang,Shengyu Yang,Keping Xie,Jihui Hao,He Ren

DOI: https://doi.org/10.1158/1078-0432.22470555

2023-01-01

Abstract:7 Supplementary Tables: Supplementary Table S1. Association between LIMS1 expression and clinicopathological features of patients with PDAC. Supplementary Table S2. Association between LIMS1 mRNA expression and clinicopathological features of PDAC patients from TCGA. Supplementary Table S3. Cox's proportional hazards model analysis of prognostic factors in patients with pancreatic ductal adenocarcinoma (PDAC) Supplementary Table S4. Association between LIMS1 expression and clinicopathological features of patients with esophageal cancer. Supplementary Table S5. Association between LIMS1 expression and clinicopathological features of patients with lung adenocarcinoma. Supplementary Table S6. Main antibodies and reagents. Supplementary Table S7. Primers and oligonucleotides sequences.
Supplementary Figure 1 from LASP1 Is a HIF1α Target Gene Critical for Metastasis of Pancreatic Cancer

Tiansuo Zhao,He Ren,Jing Li,Jing Chen,Huan Zhang,Wen Xin,Yan Sun,Lei Sun,Yongwei Yang,Junwei Sun,Xiuchao Wang,Song Gao,Chongbiao Huang,Huafeng Zhang,Shengyu Yang,Jihui Hao

DOI: https://doi.org/10.1158/0008-5472.22404603

2023-01-01

Abstract:BxPC-3 and Panc-1 cells were transfected with pcDNA3.1 and pcDNA3.1-LASP1 plasmids (2 μg) for 48 h and assessed by RT-PCR and Western blot analyses.
Table S1 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Binghao Li,Zhan Wang,Hao Wu,Mingfeng Xue,Peng Lin,Shengdong Wang,Nong Lin,Xin Huang,Weibo Pan,Meng Liu,Xiaobo Yan,Hao Qu,Lingling Sun,Hengyuan Li,Yan Wu,Wangsiyuan Teng,Zenan Wang,Xingzhi Zhou,Huabiao Chen,Mark C. Poznansky,Zhaoming Ye

DOI: https://doi.org/10.1158/0008-5472.22419831

2023-01-01

Abstract:Supplementary Table S1. Primers for qRT-PCR and MSP
Data from LASP1 is a HIF1α Target Gene Critical for Metastasis of Pancreatic Cancer

Tiansuo Zhao,Rong He,Jianbin Li,Jing Chen,Huan Zhang,Wen Xu,Yan Sun,Lei Sun,Yanling Yang,Sun Jian,Xiuchao Wang,Song Gao,Chongbiao Huang,Huafeng Zhang,Shuyuan Yang,Jihui Hao

DOI: https://doi.org/10.1158/0008-5472.c.6506631.v1

2023-01-01

Abstract:AbstractLASP1 is an actin-binding protein associated with actin assembly dynamics in cancer cells. Here, we report that LASP1 is overexpressed in pancreatic ductal adenocarcinoma (PDAC) where it promotes invasion and metastasis. We found that LASP1 overexpression in PDAC cells was mediated by HIF1α through direct binding to a hypoxia response element in the LASP1 promoter. HIF1α stimulated LASP1 expression in PDAC cells in vitro and mouse tumor xenografts in vivo. Clinically, LASP1 overexpression in PDAC patient specimens was associated significantly with lymph node metastasis and overall survival. Overall, our results defined LASP1 as a direct target gene for HIF1α upregulation that is critical for metastatic progression of PDAC. Cancer Res; 75(1); 111–9. ©2014 AACR.
Supplementary Table S4 from Receptor-interacting Protein Kinase 2 is an Immunotherapy Target in Pancreatic Cancer

Wenhua Sang,Yiduo Zhou,Haiyan Chen,Chengxuan Yu,Lisi Dai,Zhongkun Liu,Lang Chen,Yimin Fang,Panpan Ma,Xiangji Wu,Hao Kong,Wenting Liao,Hong Jiang,Junbin Qian,Da Wang,Yun-Hua Liu

DOI: https://doi.org/10.1158/2159-8290.25183960

2024-01-01

Abstract:Supplementary Table S4. Primers used for qPCR or generating knockout/knockdown constructs.
Supplementary Table 6 from linc00869 Promotes Hepatocellular Carcinoma Metastasis Via Protrusion Formation

Xiaowen Shao,Yamei Dang,Tingting Zhang,Nan Bai,Jianing Huang,Mengya Guo,Li Sun,Minghe Li,Xiao Sun,Xinran Zhang,Feng Han,Ning Zhang,Hao Zhuang,Yongmei Li

DOI: https://doi.org/10.1158/1541-7786.25325105

2024-01-01

Abstract:Table of key reagents and resources.
LASP 1 is a HIF-1 target gene critical for metastasis of pancreatic cancer Running title : The functions and regulatory mechanism of LASP-1 in PDAC

Tiansuo Zhao,H. Ren,Jing Li,J. Chen,Huan Zhang,Wen Xin,Yan Sun,Lei-Fang Sun,Yongwei Yang,Junwei Sun,Xiuchao Wang,Song Gao,Chongbiao Huang,Huafeng Zhang,Shengyu Yang,J. Hao

2014-01-01

Abstract:LASP1 is an actin-binding protein associated with actin assembly dynamics in cancer cells. Here we report that LASP1 is overexpressed in pancreatic ductal adenocarcinoma (PDAC) where it promotes invasion and metastasis. We found that LASP1 overexpression in PDAC cells was mediated by HIF-1 through direct binding to a hypoxia response element in the LASP1 promoter. HIF-1 stimulated LASP1 expression in PDAC cells in vitro and mouse tumor xenografts in vivo. Clinically, LASP1 overexpression in PDAC patient specimens was associated significantly with lymph node metastasis and overall survival. Overall, our results defined LASP1 as a direct target gene for HIF-1 upregulation that is critical for metastatic progression of PDAC.
Supplementary Figure Legends and Table Legends from Targeting LUNX Inhibits Non–Small Cell Lung Cancer Growth and Metastasis

Xiaohu Zheng,Min Cheng,Binqing Fu,Xiaolei Fan,Qing Wang,Xiaoqing Yu,Rui Sun,Zhigang Tian,Haiming Wei

DOI: https://doi.org/10.1158/0008-5472.22407638.v1

2023-01-01

Abstract:Supplementary Figure Legends
Supplementary Table S1 from Receptor-interacting Protein Kinase 2 is an Immunotherapy Target in Pancreatic Cancer

Wenhua Sang,Yiduo Zhou,Haiyan Chen,Chengxuan Yu,Lisi Dai,Zhongkun Liu,Lang Chen,Yimin Fang,Panpan Ma,Xiangji Wu,Hao Kong,Wenting Liao,Hong Jiang,Junbin Qian,Da Wang,Yun-Hua Liu

DOI: https://doi.org/10.1158/2159-8290.25191542

2024-01-01

Abstract:Supplementary Table S1. MAGeCK analysis of CRISPR screen results to identify regulator of immune evasion in orthotopic PDAC mouse models.
Supplementary Tables 1 and 2 from ESE3 Inhibits Pancreatic Cancer Metastasis by Upregulating E-Cadherin

Tiansuo Zhao,Wenna Jiang,Xiuchao Wang,Hongwei Wang,Chen Zheng,Yang Li,Yan Sun,Chongbiao Huang,Zhi-bo Han,Shengyu Yang,Zhiliang Jia,Keping Xie,He Ren,Jihui Hao

DOI: https://doi.org/10.1158/0008-5472.22416789.v1

2023-01-01

Abstract:Supplementary Table 1. Antibodies and primers Supplementary Table 2. Clinicopathologic characteristics of TMA
Supplementary Table 1 from HAb18G/CD147 Promotes Pstat3-Mediated Pancreatic Cancer Development Via CD44s

Ling Li,Wenhua Tang,Xiaoqing Wu,David Karnak,Xiaojie Meng,Rachel Thompson,Xinbao Hao,Yongmin Li,Xiaotan T. Qiao,Jiayuh Lin,James Fuchs,Diane M. Simeone,Zhi-Nan Chen,Theodore S. Lawrence,Liang Xu

DOI: https://doi.org/10.1158/1078-0432.22446368.v1

2023-01-01

Abstract:PDF file - 112K, The sequences of the oligonucleotide primers used for qPCR (related to the qRT-PCR section of Materials and Methods).
Supplementary Materials and Methods, Supplementary Figure Legends, and Supplementary Tables 1 through 5 from SSBP1 Suppresses TGFβ-Driven Epithelial-to-Mesenchymal Transition and Metastasis in Triple-Negative Breast Cancer by Regulating Mitochondrial Retrograde Signaling

Hong-Lin Jiang,He-Fen Sun,Shui-Ping Gao,Liang-Dong Li,Sheng Huang,Xin Hu,Sheng Liu,Jiong Wu,Zhi-Ming Shao,Wei Jin

DOI: https://doi.org/10.1158/0008-5472.22409469.v1

2023-01-01

Abstract:Supplementary Materials and Methods, Supplementary Figure Legends, Supplementary Table S1 Alteration of SSBP1 protein expression levels in relation to clinicopathological characteristics in breast cancer patients. Supplementary Table S2 Antibodies used in this study. Supplementary Table S3 Primers for plasmid construction. Supplementary Table S4 Primers for ChIP. Supplementary Table S5 iTRAQ: Dysregulated proteins with gene symbol.
Supplementary Figure 4 from HAb18G/CD147 Promotes Pstat3-Mediated Pancreatic Cancer Development Via CD44s

Ling Li,Wenhua Tang,Xiaoqing Wu,David Karnak,Xiaojie Meng,Rachel Thompson,Xinbao Hao,Yongmin Li,Xiaotan T. Qiao,Jiayuh Lin,James Fuchs,Diane M. Simeone,Zhi-Nan Chen,Theodore S. Lawrence,Liang Xu

DOI: https://doi.org/10.1158/1078-0432.22446374

2023-01-01

Abstract:PDF file - 263K, The effects of HAb18G/CD147 promoting pancreatic tumor development are confirmed with pGIPZ and pTRIPZ CD147 shRNA (related to Figure 1).
Supplementary Figures 5 - 6 from HAb18G/CD147 Promotes Pstat3-Mediated Pancreatic Cancer Development Via CD44s

Ling Li,Wenhua Tang,Xiaoqing Wu,David Karnak,Xiaojie Meng,Rachel Thompson,Xinbao Hao,Yongmin Li,Xiaotan T. Qiao,Jiayuh Lin,James Fuchs,Diane M. Simeone,Zhi-Nan Chen,Theodore S. Lawrence,Liang Xu

DOI: https://doi.org/10.1158/1078-0432.22446371.v1

2023-01-01

Abstract:PDF file - 451K, Figure S5: CyPA promotes HAb18G/CD147-CD44s-pSTAT3 signaling and correlated pancreatic cell growth (related to Figure 2, 3). Figure S6: HAb18G/CD147 and CD44s are co-expressed and associated in pancreatic cancer (related to Figure 4).
Supplementary Table 1 from Valosin-Containing Protein Stabilizes Mutant P53 to Promote Pancreatic Cancer Growth

Jieqiong Wang,Yajie Chen,Canhua Huang,Quan Hao,Shelya X. Zeng,Sara Omari,Yu Zhang,Xiang Zhang,Hua Liu

DOI: https://doi.org/10.1158/0008-5472.22428753.v1

2023-01-01

Abstract:Supplementary Table S1 shows the sequences of siRNAs and the targeting sequences of high scored sgRNAs for CRISPR/Cas9.
Supplementary Table 1 from MetMAb, the One-Armed 5D5 Anti-c-Met Antibody, Inhibits Orthotopic Pancreatic Tumor Growth and Improves Survival

Hongkui Jin,Renhui Yang,Zhong Zheng,Mally Romero,Jed Ross,Hani Bou-Reslan,Richard A.D. Carano,Ian Kasman,Elaine Mai,Judy Young,Jiping Zha,Zemin Zhang,Sarajane Ross,Ralph Schwall,Gail Colbern,Mark Merchant

DOI: https://doi.org/10.1158/0008-5472.22373637

2023-01-01

Abstract:Supplementary Table 1 from MetMAb, the One-Armed 5D5 Anti-c-Met Antibody, Inhibits Orthotopic Pancreatic Tumor Growth and Improves Survival
Supplementary Figures 1 - 6, Tables 1 - 3 from Amplification of Long Noncoding RNA ZFAS1 Promotes Metastasis in Hepatocellular Carcinoma

Tao Li,Junjie Xie,Chuan Shen,Dongfeng Cheng,Yuan Shi,Zhichong Wu,Xiaxing Deng,Hao Chen,Baiyong Shen,Chenghong Peng,Hongwei Li,Qian Zhan,Zhecheng Zhu

DOI: https://doi.org/10.1158/0008-5472.22406372

2023-01-01

Abstract:Supplementary Figure S1. Differentially expressed lncRNAs between HCC tissues and pair non-tumor tissues. Supplementary Figure S2. Co-expression network analysis. Supplementary Figure S3. qPCR analysis of lncRNAs. Supplementary Figure S4. qPCR analysis of miR-150 in HCC. Supplementary Figure S5. qPCR analysis of miR-150. Supplementary Figure S6. ZFAS1 positively regulates ZEB1, MMP14 and MMP16 expression in vivo. Supplementary Table S1. qPCR primers and siRNA sequences used in the study. Supplementary Table S2. Consistently upregulated or downregulated lncRNAs in GSE55191 and GSE58043 (Fold change>4.0, p<0.05) Supplementary Table S3. Core lncRNAs in the co-expression network analysis.
Supplementary Table S1 from Targeting the KIF4A/AR Axis to Reverse Endocrine Therapy Resistance in Castration-resistant Prostate Cancer

Qing Cao,Zhengshuai Song,Hailong Ruan,Cheng Wang,Yan Xiong,Bingcheng Lin,Keshan Wang,Gong Chen,Tianbo Xu,Wen Xu,Xiong Zhang,Di Liu,Ming–Hsuan Yang,Diwei Zhou,Hongmei Yang,Ke Chen,Xiaoping Zhang

DOI: https://doi.org/10.1158/1078-0432.22473300.v1

2023-01-01

Abstract:Primers used in quantitative polymerase chain reaction for analysis of genomic amplification
Supplementary Methods, Tables 1 - 2, Figure Legend from Targeting Blockage of STAT3 in Hepatocellular Carcinoma Cells Augments NK Cell Functions Via Reverse Hepatocellular Carcinoma–Induced Immune Suppression

Xiaodong Sun,Qiangjun Sui,Cai Zhang,Zhigang Tian,Jian Zhang

DOI: https://doi.org/10.1158/1535-7163.22501288

2023-01-01

Abstract:PDF file - 130K, Supplementary Table 1 Fluorochrome-conjugated antibodies used in flow cytometry.; Supplementary Table 2 Primers used in PCR.

Supplymentary Table 1 and Figure Legends from LASP1 Is a HIF1α Target Gene Critical for Metastasis of Pancreatic Cancer

Supplementary Tables from LIMS1 Promotes Pancreatic Cancer Cell Survival under Oxygen–Glucose Deprivation Conditions by Enhancing HIF1A Protein Translation

Supplementary Figure 1 from LASP1 Is a HIF1α Target Gene Critical for Metastasis of Pancreatic Cancer

Table S1 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Data from LASP1 is a HIF1α Target Gene Critical for Metastasis of Pancreatic Cancer

Supplementary Table S4 from Receptor-interacting Protein Kinase 2 is an Immunotherapy Target in Pancreatic Cancer

Supplementary Table 6 from &lt;i&gt;linc00869&lt;/i&gt; Promotes Hepatocellular Carcinoma Metastasis Via Protrusion Formation

LASP 1 is a HIF-1 target gene critical for metastasis of pancreatic cancer Running title : The functions and regulatory mechanism of LASP-1 in PDAC

Supplementary Figure Legends and Table Legends from Targeting LUNX Inhibits Non–Small Cell Lung Cancer Growth and Metastasis

Supplementary Table S1 from Receptor-interacting Protein Kinase 2 is an Immunotherapy Target in Pancreatic Cancer

Supplementary Tables 1 and 2 from ESE3 Inhibits Pancreatic Cancer Metastasis by Upregulating E-Cadherin

Supplementary Table 1 from HAb18G/CD147 Promotes Pstat3-Mediated Pancreatic Cancer Development Via CD44s

Supplementary Materials and Methods, Supplementary Figure Legends, and Supplementary Tables 1 through 5 from SSBP1 Suppresses TGFβ-Driven Epithelial-to-Mesenchymal Transition and Metastasis in Triple-Negative Breast Cancer by Regulating Mitochondrial Retrograde Signaling

Supplementary Figure 4 from HAb18G/CD147 Promotes Pstat3-Mediated Pancreatic Cancer Development Via CD44s

Supplementary Figures 5 - 6 from HAb18G/CD147 Promotes Pstat3-Mediated Pancreatic Cancer Development Via CD44s

Supplementary Table 1 from Valosin-Containing Protein Stabilizes Mutant P53 to Promote Pancreatic Cancer Growth

Supplementary Table 1 from MetMAb, the One-Armed 5D5 Anti-c-Met Antibody, Inhibits Orthotopic Pancreatic Tumor Growth and Improves Survival

Supplementary Figures 1 - 6, Tables 1 - 3 from Amplification of Long Noncoding RNA ZFAS1 Promotes Metastasis in Hepatocellular Carcinoma

Supplementary Table S1 from Targeting the KIF4A/AR Axis to Reverse Endocrine Therapy Resistance in Castration-resistant Prostate Cancer

Supplementary Methods, Tables 1 - 2, Figure Legend from Targeting Blockage of STAT3 in Hepatocellular Carcinoma Cells Augments NK Cell Functions Via Reverse Hepatocellular Carcinoma–Induced Immune Suppression

Supplementary Table 6 from <i>linc00869</i> Promotes Hepatocellular Carcinoma Metastasis Via Protrusion Formation